Literature DB >> 20227268

STAT5 in B cell development and leukemia.

Stephen Malin1, Shane McManus, Meinrad Busslinger.   

Abstract

Early B cell development depends on a network of transcription factors, whereby E2A and EBF1 regulate B cell specification and Pax5 controls B-lineage commitment. In contrast, activation of the transcription factor STAT5 in response to IL-7R signaling promotes cell survival by activating the prosurvival gene Mcl1 and orders immunoglobulin gene rearrangement by repressing Igk recombination in pro-B cells. Subsequently, it cooperates with the pre-B cell receptor to facilitate pre-B cell expansion. STAT5 also plays a key role in the generation of B cell precursor acute lymphoblastic leukemia, whereby the BCR-ABL1 translocation or the collaboration of JAK2 mutations with overexpression of the thymic stromal lymphopoietin receptor CRLF2 results in constitutive STAT5 activation leading to cytokine-independent survival and growth of leukemic cells. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227268     DOI: 10.1016/j.coi.2010.02.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  40 in total

1.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

2.  STAT5 alters the state of transcriptional networks, driving aggressive leukemia.

Authors:  Sinisa Dovat; Kimberly J Payne
Journal:  Nat Immunol       Date:  2017-05-18       Impact factor: 25.606

3.  Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia.

Authors:  Valentina Minieri; Marco De Dominici; Patrizia Porazzi; Samanta A Mariani; Orietta Spinelli; Alessandro Rambaldi; Luke F Peterson; Pierluigi Porcu; Marja T Nevalainen; Bruno Calabretta
Journal:  Cancer Res       Date:  2018-08-28       Impact factor: 12.701

Review 4.  IL-7: the global builder of the innate lymphoid network and beyond, one niche at a time.

Authors:  Joonsoo Kang; Mark Coles
Journal:  Semin Immunol       Date:  2012-03-13       Impact factor: 11.130

Review 5.  B-lymphocyte lineage cells and the respiratory system.

Authors:  Atsushi Kato; Kathryn E Hulse; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

6.  Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels.

Authors:  A Margarida Gomes; Maria V D Soares; Patrícia Ribeiro; Joana Caldas; Vanda Póvoa; Leila R Martins; Alice Melão; Ana Serra-Caetano; Aida B de Sousa; João F Lacerda; João T Barata
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

Review 7.  Transcriptional control of early T and B cell developmental choices.

Authors:  Ellen V Rothenberg
Journal:  Annu Rev Immunol       Date:  2014-01-22       Impact factor: 28.527

8.  An SH2 domain model of STAT5 in complex with phospho-peptides define "STAT5 Binding Signatures".

Authors:  Eleonora Gianti; Randy J Zauhar
Journal:  J Comput Aided Mol Des       Date:  2015-03-10       Impact factor: 3.686

9.  The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development.

Authors:  Haiyan S Li; Cliff Y Yang; Kalyan C Nallaparaju; Huiyuan Zhang; Yong-Jun Liu; Ananda W Goldrath; Stephanie S Watowich
Journal:  Blood       Date:  2012-10-01       Impact factor: 22.113

Review 10.  Lymphocyte development: integration of DNA damage response signaling.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.